PolyPeptide Group AG (SWX:PPGN)
Switzerland
· Delayed Price · Currency is CHF 24.45
+0.70 (2.95%)
At close: Mar 9, 2026
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 783.55 million as of March 9, 2026. Its market cap has increased by 3.06% in one year.
Market Cap
783.55M
Enterprise Value
815.88M
Revenue
344.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.45
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 783.55M, a decrease of -69.75%. That is a compound annual growth rate of -21.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 806.64M | -6.32% |
| Dec 30, 2025 | 861.08M | -8.08% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 272.66B |
| Novartis AG | 235.20B |
| Galderma Group AG | 36.57B |
| Lonza Group AG | 35.02B |
| Tecan Group AG | 1.60B |
| Aevis Victoria | 1.18B |
| SKAN Group AG | 1.10B |
| Kuros Biosciences AG | 1.04B |